Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;2(11):e653-e655.
doi: 10.1016/S2665-9913(20)30309-X. Epub 2020 Sep 5.

Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment

Philip C Robinson  1   2 , Duncan Richards  3 , Helen L Tanner  1   2 , Marc Feldmann  3
Affiliations

Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment

Philip C Robinson et al. Lancet Rheumatol. 2020 Nov.
No abstract available

PubMed Disclaimer

References

    1. Feldmann M, Maini RN, Woody JN. Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Lancet. 2020;395:1407–1409. - PMC - PubMed
    1. Del Valle DM, Kim-Schulze S, Huang H. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020 doi: 10.1038/s41591-020-1051-9. published online Aug 24. - DOI - PMC - PubMed
    1. Lee JS, Park S, Jeong HW. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci Immunol. 2020;4 - PMC - PubMed
    1. Charles P, Elliott MJ, Davis D. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. J Immunol. 1999;163:1521–1528. - PubMed
    1. Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M. Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet. 1989;2:244–247. - PubMed

LinkOut - more resources